Clinical Update in the Diagnosis, Treatment, and Management of CIDP


Want a discount? Become a member by purchasing Corporate Membership, Enterprise Corporate Membership or Individual Membership!



Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc.

Original Release Date: May 2018
Release Date: February 2024
Expiration Date: February 2025

Speaker: Dr. Richard Lewis
Speaker: Dr. Mazen Dimachkie
Speaker: Jeffrey Rosenfeld , MD, PhD

Continuing Education: Nursing 2 contact hour | Pharmacy 2 contact hour

Recertification: 2 IgCN® / IgCP® Recertification Units

Target Audience

This activity is intended for pharmacists and nurses who care for patients with CIDP.

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

Session 1:

  • Describe the diagnostic triad used for evaluating patients
  • Describe the role of auto-antibodies in CIDP
  • Describe the four variants of CIDP

Session 2:

  • List three factors of consideration in determining to initiate therapy
  • Describe three treatment options for CIDP
  • Discuss the risks and benefits of CIDP treatment modalities

Session 3:

  • Describe two characteristics of CIDP
  • Discuss three techniques to evaluate clinical response to Ig therapy
  • Compare and contrast IVIG vc SCIG in managing CIDP